Wegovy®
A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
- ~16.9% average body weight loss
- Boosts metabolic & cardiovascular health
- Proven, long-established safety profile
- Weekly injection, easy to use

Can you take magnesium with Saxenda? Many patients prescribed Saxenda (liraglutide) for weight management wonder whether magnesium supplementation is safe alongside their treatment. Saxenda is a GLP-1 receptor agonist that helps control appetite and support weight loss, whilst magnesium is an essential mineral involved in hundreds of bodily processes. As calorie restriction during weight management may affect micronutrient intake, understanding potential interactions between Saxenda and magnesium supplements is important. This article examines the evidence on concurrent use, explores practical considerations, and provides guidance for patients and healthcare professionals on safely combining these substances.
Summary: Yes, you can safely take magnesium supplements with Saxenda, as there is no official contraindication or known direct drug interaction between them.
Saxenda (liraglutide 3 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity or those who are overweight with weight-related health conditions. It belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking a naturally occurring hormone that regulates appetite and food intake. Saxenda slows gastric emptying, increases feelings of fullness, and reduces hunger signals in the brain, thereby helping patients achieve and maintain weight loss when combined with a reduced-calorie diet and increased physical activity.
Magnesium is an essential mineral involved in over 300 enzymatic reactions in the body, including energy production, protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation. Some people may not meet the Reference Nutrient Intake (RNI) for magnesium (300 mg for men and 270 mg for women), though most can achieve adequate intake through a balanced diet. Common supplemental forms include magnesium citrate, magnesium oxide, and magnesium glycinate, each with varying absorption rates and bioavailability.
When embarking on a weight management programme with Saxenda, patients often consider nutritional supplementation to support overall health, particularly as calorie restriction may affect micronutrient intake. Understanding whether magnesium can be safely taken alongside Saxenda is important for those wishing to optimise their nutritional status whilst undergoing treatment. This article examines the evidence surrounding concurrent use of these substances and provides practical guidance for patients and healthcare professionals.

There is no official contraindication or known direct drug interaction between magnesium supplements and Saxenda. The Medicines and Healthcare products Regulatory Agency (MHRA) approved product information for Saxenda does not list magnesium as an interacting substance, and the pharmacological mechanisms of liraglutide do not suggest interference with magnesium absorption, metabolism, or excretion. Magnesium is primarily absorbed in the small intestine through both passive and active transport mechanisms, whilst Saxenda exerts its effects through GLP-1 receptors located throughout the body, including the pancreas, brain, and gastrointestinal tract.
From a physiological perspective, taking magnesium supplements alongside Saxenda should not compromise the efficacy of either substance. Saxenda is administered as a subcutaneous injection, bypassing initial gastrointestinal absorption. However, it is important to note that Saxenda slows gastric emptying, which is part of its therapeutic mechanism. This delayed stomach emptying could theoretically affect the timing of absorption of some oral medicines, particularly those with a narrow therapeutic window, though there is no clinical evidence to suggest this causes any significant problems with magnesium supplements specifically.
Most patients taking Saxenda can safely incorporate magnesium supplementation into their daily routine without adverse effects. That said, individual circumstances vary, and certain considerations regarding gastrointestinal tolerance and overall supplement regimens should be taken into account, which are discussed in subsequent sections.
Whilst there is no direct pharmacological interaction between magnesium and Saxenda, several practical considerations warrant attention. The most common side effects of Saxenda involve the gastrointestinal system, including nausea, vomiting, diarrhoea, constipation, and abdominal discomfort. These effects are particularly pronounced during the initial titration phase when the dose is gradually increased. Magnesium supplements, particularly magnesium citrate and magnesium oxide, can have a laxative effect, especially at higher doses. Taking magnesium alongside Saxenda may therefore exacerbate gastrointestinal symptoms, particularly diarrhoea.
Patients experiencing significant gastrointestinal side effects from Saxenda should consider the form and timing of magnesium supplementation. Magnesium glycinate tends to be better tolerated and less likely to cause loose stools compared to magnesium citrate or oxide. Splitting the magnesium dose throughout the day rather than taking it all at once may also improve tolerance.
Another consideration relates to overall nutritional status during weight loss. Calorie restriction, which accompanies Saxenda treatment, may affect intake of various nutrients including magnesium. Ensuring adequate magnesium intake through diet (green leafy vegetables, nuts, seeds, whole grains, and legumes) or supplementation can support metabolic health and muscle function.
It is important to note that excessive magnesium supplementation can lead to hypermagnesaemia, particularly in individuals with impaired kidney function. The NHS advises that taking 400 mg or less of magnesium from supplements daily is unlikely to cause harm. Symptoms of excess include nausea, low blood pressure, confusion, and in severe cases, cardiac arrhythmias. Patients with chronic kidney disease should exercise particular caution and consult their healthcare provider before starting magnesium supplements.
Magnesium can also interact with certain medications by forming complexes that reduce absorption. These include tetracycline and quinolone antibiotics, levothyroxine, and bisphosphonates. If you take these medicines, separate them from magnesium supplements by at least 2-4 hours. Combined gastrointestinal effects from Saxenda and magnesium may increase dehydration risk, so maintaining adequate fluid intake is essential, especially for those with kidney problems or taking nephrotoxic medications.
Whilst magnesium supplementation is generally considered safe for most people taking Saxenda, there are specific circumstances when professional medical advice is essential. Patients should consult their GP, prescribing clinician, or pharmacist before starting magnesium supplements if they:
Have chronic kidney disease or impaired renal function, as the kidneys regulate magnesium excretion and supplementation may lead to dangerous accumulation
Are taking medications that affect kidney function or electrolyte balance, including certain diuretics, ACE inhibitors, or specific antibiotics
Have a history of cardiac arrhythmias or are taking medications for heart conditions
Experience persistent or severe gastrointestinal symptoms whilst taking Saxenda, as adding magnesium may worsen these effects
Are taking multiple supplements or medications, as cumulative effects need professional assessment
Are taking medications known to interact with magnesium, such as tetracyclines, quinolones, levothyroxine, or bisphosphonates
Have diabetes requiring insulin or sulfonylureas, as both Saxenda and magnesium may influence blood glucose control, and dose adjustments of diabetes medications may be needed to prevent hypoglycaemia
Patients should stop Saxenda and seek urgent medical attention if they experience severe, persistent abdominal pain (which may radiate to the back), with or without vomiting, as these could be signs of acute pancreatitis. Similarly, symptoms of gallbladder disease require prompt medical evaluation.
Seek urgent medical attention if you experience symptoms potentially related to magnesium toxicity, including severe diarrhoea, muscle weakness, irregular heartbeat, difficulty breathing, or confusion. Similarly, if gastrointestinal side effects from Saxenda become intolerable or persistent, medical review is necessary to assess whether dose adjustment or alternative management strategies are required.
It is also advisable to inform your healthcare provider about all supplements you are taking during routine Saxenda monitoring appointments. NICE guidance on obesity management emphasises the importance of comprehensive nutritional assessment as part of weight management programmes, and your healthcare team can provide personalised advice on appropriate supplementation based on your individual health status, dietary intake, and treatment response.
If you suspect any adverse reactions to either Saxenda or magnesium supplements, report them to the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or via the Yellow Card app).
To optimise safety and efficacy when combining magnesium supplementation with Saxenda treatment, consider the following evidence-based recommendations:
Timing and dosing: Take magnesium supplements at a consistent time each day, preferably with food to enhance absorption and reduce gastrointestinal upset. There is no need to separate magnesium from your Saxenda injection, as they work through different mechanisms and routes of administration. The Reference Nutrient Intake (RNI) for magnesium in UK adults is 300 mg for men and 270 mg for women; supplementation should aim to meet but not greatly exceed these levels. The NHS advises that taking 400 mg or less of magnesium from supplements daily is unlikely to cause harm for most people.
Choose appropriate formulations: Select magnesium supplements that are well-tolerated and bioavailable. Magnesium glycinate is often preferred for supplementation as it tends to be gentle on the digestive system. Magnesium citrate is well absorbed but may have a laxative effect, which could compound Saxenda's gastrointestinal side effects. Avoid high doses of magnesium oxide, which has lower bioavailability and stronger laxative effects.
Separate from certain medications: If you take tetracycline or quinolone antibiotics, levothyroxine, or bisphosphonates, separate these from your magnesium supplement by at least 2-4 hours to prevent reduced absorption of these medicines.
Monitor your response: Keep track of any gastrointestinal symptoms, particularly during the first few weeks of Saxenda treatment when side effects are most common. If diarrhoea or other digestive issues worsen after starting magnesium, consider reducing the dose, changing the formulation, or temporarily discontinuing supplementation whilst your body adjusts to Saxenda.
Stay hydrated: Maintain adequate fluid intake, especially if you experience diarrhoea or vomiting, to prevent dehydration and potential kidney problems.
Prioritise dietary sources: Whenever possible, obtain magnesium through whole food sources including spinach, almonds, cashews, black beans, edamame, peanut butter, wholemeal bread, and avocado. A balanced, nutrient-dense diet supports overall health during weight loss and reduces reliance on supplements.
Maintain open communication: Inform all members of your healthcare team about your supplement regimen, including your GP, prescribing clinician, pharmacist, and any dietitians or nutritionists involved in your care. This ensures coordinated, safe management of your weight loss programme and overall health. Regular monitoring of weight loss progress, side effects, and nutritional status should be part of your Saxenda treatment plan, in line with NICE recommendations for obesity management.
No, magnesium supplements do not affect Saxenda's efficacy. Saxenda is administered by subcutaneous injection and works through GLP-1 receptors, whilst magnesium is absorbed in the small intestine through different mechanisms, so they do not interfere with each other's action.
Magnesium glycinate is often the best choice when taking Saxenda, as it tends to be gentle on the digestive system and less likely to cause diarrhoea. Magnesium citrate and oxide have stronger laxative effects that may worsen Saxenda's gastrointestinal side effects.
Whilst generally safe for most people, you should consult your GP or prescribing clinician before starting magnesium if you have chronic kidney disease, cardiac arrhythmias, take medications affecting kidney function or electrolyte balance, or experience persistent gastrointestinal symptoms with Saxenda.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript